Subscribe to Here’s the Deal, our politics
newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
More than two years into the pandemic, most Americans have returned to a sense of some normalcy. But the virus is still disrupting daily life in the U.S. with more than 130,000 per day and deaths on the rise. We…
By News Desk and Associated Press
The nation’s top infectious disease expert says in order to keep up with ever evolving COVID-19, we need to be "flexible" to move with the changing virus.
By Matthew Perrone, Associated Press
More than 100,000 monkeypox vaccine doses are being sent to states in the next few days, and several million more are on order in the months ahead, U.S. health officials said Friday.
The FDA said it has completed a required inspection of the overseas plant where the shots are manufactured. The update comes amid soaring demand in New York City, California and other parts of the U.S.
With vaccinations, boosters and drugs, COVID has become a far less deadly risk for most Americans than earlier in the pandemic. But COVID still presents numerous problems, particularly for some of the most vulnerable people, with an average of more…
The Biden administration has launched a vaccination campaign against monkeypox, making nearly 300,000 shots available in the coming weeks. There are around 350 known cases of the virus in the U.S., and zero deaths, but there are concerns about its…
By Laura Santhanam
What a pediatrician recommends serves as a strong predictor of whether or not a caregiver chooses to get their child vaccinated against COVID.
White House officials on Thursday will hold a briefing on COVID vaccine authorization for young kids.
By Maria Cheng, Chinedu Asadu, Associated Press
As health authorities in Europe and elsewhere scramble to roll out vaccines and drugs to stamp out the biggest monkeypox outbreak beyond Africa, some doctors are acknowledging an ugly reality: The resources needed to prevent the disease have long been…
By Mayuresh Abhyankar, The Conversation
Research suggests that giving a person a vaccine through their nose can provide a better defense against future exposure to the coronavirus compared to a shot in the arm.
Support Provided By: